Significant demographic and clinical differences exist between typical primary care stroke populations and PROGRESS trial participants, challenging the direct applicability of trial-based guidelines.
No takes yet. Share an insight, caveat, or question.
Demographic mismatches may limit PROGRESS guideline applicability in primary care; leaves open whether BP targets require real-world validation.
Mant et al. (2006) studied this question.